The question needs a straight answer. Bariatric surgery is called extreme far more often than obesity itself is. That imbalance reflects how this condition is still viewed, by the public and, at times ...

Scientists have discovered novel molecular mechanisms that contribute to recovery from diabetic kidney disease following bariatric surgery in adolescents with type 2 diabetes and obesity, mechanisms ...

Since late 2022, rising uptake of GLP-1 medications for obesity has coincided with a decline in bariatric surgeries, according to a growing body of research. Researchers at Ohio State University ...

The prevalence of GLP-1 prescriptions increased dramatically from 0.22% in quarter 4 of 2018 to 24.17% in quarter 3 of 2025, representing more than a 100-fold increase over the study period. Metabolic ...

Bariatric surgery is a weight loss procedure you can opt for if you’re overweight. The procedure will help reduce your intake of food, making it ideal for long-term weight loss. Worldometer reports ...

Please provide your email address to receive an email when new articles are posted on . Higher measured GFR before bariatric surgery was linked to greater GFR reductions after surgery. Combined ...

Bariatric surgery is a key offering for many ASCs and gastroenterology practices, despite declines in inpatient surgical volumes for the procedure. Here are five things to know about the recent ...

DOCTOR, WEIGHT LOSS MEDICATION HAS BEEN ALL OVER THE HEADLINES. BUT ARE THEY REALLY YOUR BEST OPTION FOR WEIGHT LOSS? WELL, MERCY MEDICAL CENTER DOCTOR KULDEEP SINGH IS JOINING US LIVE WITH MORE. AND ...

More than 37 million Americans have type 2 diabetes, a chronic disorder affecting the body's ability to regulate and use sugar. According to the CDC, it's the country's seventh leading cause of death.

Metabolic bariatric surgery is associated with a lower risk of major adverse cardiovascular events, as well as a lower risk of all-cause mortality, nephropathy, and retinopathy, when compared with ...

Bariatric surgery is more cost-effective than GLP-1 RAs for obesity treatment, with lower long-term costs and greater weight loss outcomes. The study found that bariatric surgery led to fewer ...

GLP-1 agonists are increasingly used post-bariatric surgery, with semaglutide being the most common, especially among younger, female, and Black or African American patients. The study highlights the ...